1. Mitchell C, Bowen A, Tyson S, Butterfint Z, Conroy P. Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury. The Cochrane database of systematic reviews. 2017;1(1):Cd002088.
2. Yorkston Kathryn M. Treatment Efficacy. Journal of Speech, Language, and Hearing Research. 1996;39(5):S46-S57.
3. Brady MC, Clark AM, Dickson S, Paton G, Barbour RS. The impact of stroke-related dysarthria on social participation and implications for rehabilitation. Disability and rehabilitation. 2011;33(3):178-86.
4. Dickson S, Barbour RS, Brady M, Clark AM, Paton G. Patients' experiences of disruptions associated with post-stroke dysarthria. International journal of language & communication disorders. 2008;43(2):135-53.
5. Mackenzie C. Dysarthria in stroke: a narrative review of its description and the outcome of intervention. International journal of speech-language pathology. 2011;13(2):125-36.
6. Mackenzie C, Bennett A, Cairney M. Active citizenship and acquired neurological communication difficulty. Disability and rehabilitation. 2011;33(3):187-94.
7. Flowers HL, Silver FL, Fang J, Rochon E, Martino R. The incidence, co-occurrence, and predictors of dysphagia, dysarthria, and aphasia after first-ever acute ischemic stroke. Journal of communication disorders. 2013;46(3):238-48.
8. Lawrence ES, Coshall C, Dundas R, Stewart J, Rudd AG, Howard R, et al. Estimates of the prevalence of acute stroke impairments and disability in a multiethnic population. Stroke. 2001;32(6):1279-84.
9. Sellars C, Hughes T, Langhorne P. Speech and language therapy for dysarthria due to non-progressive brain damage. The Cochrane database of systematic reviews. 2005(3):Cd002088.
10. Arefyeva AP, Skripkina NA, Vasenina EE. [Speech disorders in Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova. 2019;119(9. Vyp. 2):32-6.
11. Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P. Treatments for dysarthria in Parkinson's disease. The Lancet Neurology. 2004;3(9):547-56.
12. Dashtipour K, Tafreshi A, Lee J, Crawley B. Speech disorders in Parkinson's disease: pathophysiology, medical management and surgical approaches. Neurodegenerative disease management. 2018;8(5):337-48.
13. Balchin R, Hersh D, Grantis J, Godfrey M. "Ode to confidence": Poetry groups for dysarthria in multiple sclerosis. International journal of speech-language pathology. 2020;22(3):347-58.
14. Rusz J, Vaneckova M, Benova B, Tykalova T, Novotny M, Ruzickova H, et al. Brain volumetric correlates of dysarthria in multiple sclerosis. Brain and language. 2019;194:58-64.
15. Conway A, Walshe M. Management of non-progressive dysarthria: practice patterns of speech and language therapists in the Republic of Ireland. International journal of language & communication disorders. 2015;50(3):374-88.
16. Rumbach AF, Finch E, Stevenson G. What are the usual assessment practices in adult non-progressive dysarthria rehabilitation? A survey of Australian dysarthria practice patterns. Journal of communication disorders. 2019;79:46-57.
17. Walshe M, Miller N. Living with acquired dysarthria: the speaker's perspective. Disability and rehabilitation. 2011;33(3):195-203.
18. World Health O. ICF : International classification of functioning, disability and health / World Health Organization. Geneva: World Health Organization; 2001.
19. Dykstra AD, Hakel ME, Adams SG. Application of the ICF in reduced speech intelligibility in dysarthria. Seminars in speech and language. 2007;28(4):301-11.
20. Miller N, Bloch S. A survey of speech-language therapy provision for people with post-stroke dysarthria in the UK. International journal of language & communication disorders. 2017;52(6):800-15.
21. Geddes JM, Fear J, Tennant A, Pickering A, Hillman M, Chamberlain MA. Prevalence of self reported stroke in a population in northern England. J Epidemiol Community Health. 1996;50(2):140-3.
22. O'Mahony PG, Thomson RG, Dobson R, Rodgers H, James OF. The prevalence of stroke and associated disability. Journal of public health medicine. 1999;21(2):166-71.
23. Murdoch BE, Theodoros DG. Traumatic brain injury: associated speech, language, and swallowing disorders. San Diego: Singular/Thomson Learning; 2001.
24. Lahoud N, Salameh P, Saleh N, Hosseini H. Prevalence of Lebanese stroke survivors: A comparative pilot study. Journal of Epidemiology and Global Health. 2016;6(3):169-76.
25. Abou-Abbass H, Bahmad H, Ghandour H, Fares J, Wazzi-Mkahal R, Yacoub B, et al. Epidemiology and clinical characteristics of traumatic brain injury in Lebanon: A systematic review. Medicine. 2016;95(47):e5342.
26. Williams JR. The Declaration of Helsinki and public health. Bull World Health Organ. 2008;86(8):650-2.
27. Auzou P, Rolland-Monnoury V. BECD : batterie d'évaluation clinique de la dysarthrie2006.
28. Enderby PM, Palmer R, Pro E. FDA-2 : Frenchay Dysarthria Assessment : Examiner's Manual. Austin, TX: Pro-Ed; 2008.
29. Enderby PM. Frenchay dysarthria assessment: San Diego, Calif. : College-Hill Press, [1983] ©1983; 1983.
30. Knuijt S, Kalf J, Van Engelen B, de Swart B, Geurts A. The Radboud Dysarthria Assessment: Development and Clinimetric Evaluation2017. 143-53 p.
31. Khalaf M, Matar N. Translation and transcultural adaptation of the VHI-10 questionnaire: the VHI-10lb. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2017;274(8):3139-45.
32. Coster WJ. Making the best match: selecting outcome measures for clinical trials and outcome studies. The American journal of occupational therapy : official publication of the American Occupational Therapy Association. 2013;67(2):162-70.
33. Clark HM. Neuromuscular Treatments for Speech and Swallowing. American Journal of Speech-Language Pathology. 2003;12(4):400-15.
34. Collis J, Bloch S. Survey of UK speech and language therapists' assessment and treatment practices for people with progressive dysarthria. International journal of language & communication disorders. 2012;47(6):725-37.